Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NRP1 | O14786 | 2/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 9/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 9/20 | 0.46 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.43 |
| ▸ | GRB2 | P62993 | 1/20 | 0.42 |
| ▸ | RAMP3 | O60896 | 5/20 | 0.41 |
| ▸ | CALCR | P30988 | 5/20 | 0.41 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.41 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.41 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22803169 | 0.95 | NRP1 (0.45) | NRP1OPRM1OPRK1EPHA2GRB2 | |
| SCHEMBL29535207 | 0.89 | OPRM1 (0.52) | NRP1OPRM1OPRK1EPHA2RAMP3 | |
| SCHEMBL22872708 | 0.89 | NRP1 (0.54) | NRP1OPRM1OPRK1EPHA2GRB2 | |
| SCHEMBL20694547 | 0.89 | NRP1 (0.46) | NRP1OPRM1OPRK1EPHA2GRB2 | |
| SCHEMBL29723642 | 0.88 | OPRM1 (0.51) | NRP1OPRM1OPRK1EPHA2 | |
| SCHEMBL29571627 | 0.88 | NRP1 (0.54) | NRP1OPRM1OPRK1 | |
| SCHEMBL24716410 | 0.87 | NRP1 (0.45) | NRP1OPRM1OPRK1EPHA2GRB2 | |
| SCHEMBL30452201 | 0.86 | NRP1 (0.43) | NRP1OPRM1OPRK1EPHA2GRB2 | |
| SCHEMBL29801770 | 0.86 | OPRM1 (0.48) | NRP1OPRM1OPRK1 | |
| SCHEMBL22803170 | 0.85 | NRP1 (0.42) | NRP1OPRM1OPRK1EPHA2GRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112159461-B | Synthesis method of cetrorelix | 开封明仁药业有限公司 | 2023-03-10 | — | — | CN | disclosed |